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Abstract
The clinicopathological features of the hamster model of visceral leishmaniasis (VL) closely mimic active human disease.
Studies in humans and hamsters indicate that the inability to control parasite replication in VL could be related to ineffective
classical macrophage activation. Therefore, we hypothesized that the pathogenesis of VL might be driven by a program of
alternative macrophage activation. Indeed, the infected hamster spleen showed low NOS2 but high arg1 enzyme activity
and protein and mRNA expression (p,0.001) and increased polyamine synthesis (p,0.05). Increased arginase activity was
also evident in macrophages isolated from the spleens of infected hamsters (p,0.05), and arg1 expression was induced by
L. donovani in primary hamster peritoneal macrophages (p,0.001) and fibroblasts (p,0.01), and in a hamster fibroblast cell
line (p,0.05), without synthesis of endogenous IL-4 or IL-13 or exposure to exogenous cytokines. miRNAi-mediated
selective knockdown of hamster arginase 1 (arg1) in BHK cells led to increased generation of nitric oxide and reduced
parasite burden (p,0.005). Since many of the genes involved in alternative macrophage activation are regulated by Signal
Transducer and Activator of Transcription-6 (STAT6), and because the parasite-induced expression of arg1 occurred in the
absence of exogenous IL-4, we considered the possibility that L. donovani was directly activating STAT6. Indeed, exposure of
hamster fibroblasts or macrophages to L. donovani resulted in dose-dependent STAT6 activation, even without the addition
of exogenous cytokines. Knockdown of hamster STAT6 in BHK cells with miRNAi resulted in reduced arg1 mRNA expression
and enhanced control of parasite replication (p,0.0001). Collectively these data indicate that L. donovani infection induces
macrophage STAT6 activation and STAT6-dependent arg1 expression, which do not require but are amplified by type 2
cytokines, and which contribute to impaired control of infection.
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Introduction
In humans, active visceral leishmaniasis (VL), caused by the
intracellular protozoan Leishmania donovani, is a progressive,
potentially fatal infection characterized by chronic, fever,
hepatosplenomegaly, pancytopenia, and profound cachexia. VL
remains a significant cause of morbidity and mortality in the
developing world; hundreds of thousands of people have died in
recent years in epidemics in Sudan and India.
Most experimental studies of infection with the visceralizing
Leishmania (L. donovani and L. infantum/chagasi) have used the murine
infection model. Mice are genetically resistant or susceptible to L.
donovani, but even susceptible strains are able to contain the
infection without overt disease [1]. L. donovani-infected mice mount
a vigorous anti-leishmanial type 1 CD4+ and CD8+ T cell
response that leads to control of the infection, primarily through
the upregulation of inducible nitric oxide synthase 2 (iNOS or
NOS2) and generation of nitric oxide (NO) in the spleen and
liver [2–4]. Susceptibility in the murine L. donovani infection
model is related to the expression of IL-10 [5,6] and TGF-b [7].
Notably, IL-4, which has a prominent role in the immunopatho-
genesis of murine L. major infection (reviewed in [8]), appears to
have a limited role in the pathogenesis of murine L. donovani
infection [9]. While study of the chronic, self-controlled infection
in mice has been instrumental in dissecting mechanisms of
immunity and susceptibility, this model may be limited in
representing the mechanistic underpinnings of progressive
visceral disease.
The underlying immunopathogenic mechanisms related to
human VL have not been fully elucidated. In human VL there
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plasma [10,11] and in the infected lymph node, bone marrow,
and spleen [12–14]. Paradoxically, this robust type 1 cytokine
response, which typically mediates control of intracellular
pathogens, does not mitigate the relentlessly progressive disease
in humans. Several cytokines known to impair macrophage-
mediated killing of Leishmania [15] have been postulated to have
a detrimental role in human VL [16,17]. The Th2 cytokines,
interleukin (IL)-4 and IL-13, which play a prominent role in
promotion of disease in some experimental models of Leishmania
infection [8], were found to be increased in the serum of patients
with active VL in some [18–21], but not all studies [22–24]. The
importance of IL-10 in the pathogenesis of human VL is more
clearly established [16]. Patientsw i t hV Lh a v ee l e v a t e dl e v e l so f
IL-10 in serum or plasma [22–25] and increased IL-10 mRNA
expression in the spleen and bone marrow [13,14,19]. In vitro
neutralization of IL-10 in peripheral blood mononuclear cell
cultures from patients with VL resulted in enhancement
of type 1 T cell responses to Leishmania antigens [12,26], and
neutralization of IL-10 in splenic aspirates promoted parasite
clearance [27]. Impairment of signaling pathways in human
macrophages infected in vitro with Leishmania is also well
described (reviewed in [28]) and may play a role in human VL
by rendering the infected cells less responsive to activating
stimuli.
In light of the ineffective killing of L. donovani in human VL, it is
pertinent to consider the activation phenotypes of macrophages.
Classically activated macrophages are primed by proinflamma-
tory cytokines, most notably IFN-c, and triggered by microbial
products to produce antimicrobial mediators such as NO and
reactive oxygen species. These macrophages play a critical role in
the protection against intracellular pathogens such as Leishmania
[2,29–35]. Macrophages exposed to type 2 cytokines (IL-4 and
IL-13) were thought initially to be in a deactivated state because
of blunting of the pro-inflammatory cytokine response, oxidative
burst, or NO response [15]. However, it is now recognized that
these macrophages are not paralyzed, but in fact display a
different activation program. Alternatively activated macrophag-
es (AAMs), as introduced by Gordon and colleagues in describing
the phenotype of macrophages activated in the presence of IL-4
(and later IL-13) [36,37], fail to produce NO, have pronounced
arginase activity (which competes with NOS2 for the common
substrate arginine), and fail to control the intracellular replication
of pathogens, including Leishmania [38,39]. Recently, a role for
IL-21 in the amplification of arginase-producing alternatively
activated macrophages has been identified [40]. Alternatively
activated macrophages play an important role in dampening
tissue inflammation, and mediating tissue repair and wound
healing.
AAMs play a role in the pathogenesis of protozoal infections
[41], and several lines of evidence from the murine L. major
infection model identified an important role of AAMs in
promoting Leishmania infection. First, the constitutive expression
of arg1 was higher in macrophages from L. major-susceptible
compared to resistant mice [42]. Second, arg1 induction
correlated with lesion size in mice infected with L. major [43,44].
Third, AAMs failed to control the intracellular replication of
pathogens, including Leishmania [38,39]. Fourth, the upregulation
of arginase by IL-4, IL-10, and TGF-b was associated with
impaired capacity to kill intracellular L. major [42–44]. Finally,
inhibition of arginase decreased disease and parasite burden in L.
major infected mice and macrophages [43,44]. The increased
expression of host arg1 has two important downstream effects that
can promote Leishmania infection: (1) arginase competes with
NOS2 for the common substrate, arginine, thereby reducing the
generation of the antimicrobial molecule NO; and (2) arginase
activity leads to the generation of polyamines that can be
scavenged through uptake receptors [45] to promote Leishmania
growth [46].
Unfortunately, there remain significant deficits in our
understanding of the molecular and cellular determinants
underlying VL pathogenesis. The Syrian hamster (Mesocricetus
auratus) affords a unique opportunity to address questions related
to the pathogenesis of visceral leishmaniasis, because the
clinicopathological features of the hamster model of VL mimic
active human disease. We, and others, demonstrated that
despite progressive disease hamsters with VL mount a vigorous
type 1 cellular immune response [47–49], an immunological
e v e n tt h a ti st y p i c a l l ya s s o c i a ted with disease control and
resolution. This paradoxical finding was reminiscent of the
findings in humans [13,14], and suggested that the inability to
control parasite replication could be related to ineffective IFN-
c-mediated induction of classical macrophage activation.
Indeed, we found that the expression of NOS2 and production
of NO, which is the primary mechanism by which mice control
Leishmania infection [2,29–35], was low during the progressive
course of disease in hamster VL [48,49]. Because of the low
NOS2 expression in hamsters with VL we hypothesized that
during progressive disease macrophages would default toward
and/or be driven toward an alternatively activated phenotype.
Indeed, the expression of arg1 and the production of polyamines
was dominant in progressive VL. However, distinct from the
prevailing paradigm of cytokine-mediated alternative activation
of macrophages, we found that the L. donovani-induced
activation of STAT6 and arg1 expression and polyamine
production in macrophages and fibroblasts did not require the
presence of a polarized Th2 response or synthesis of type 2
cytokines. The critical importance of the parasite-induced
STAT6-arg1 pathway in infected cells was demonstrated by
finding enhanced control of infection following either STAT6 or
arg1 knockdown.
Author Summary
Visceral leishmaniasis (VL), caused by the intracellular
protozoan Leishmania donovani, is a progressive, poten-
tially fatal infection found in many resource-poor regions
of the world. We initiated these studies of an experimental
model of VL to better understand the molecular and
cellular determinants underlying this disease. We found
that host macrophages or fibroblasts, when infected with
Leishmania donovani or exposed to products secreted by
the parasite, are permissive to infection because they fail
to metabolize arginine to generate nitric oxide, the
effector molecule needed to kill the intracellular parasites.
Instead, the infected host cells are activated in a way that
leads to the expression of arginase, an enzyme that
metabolizes arginine to produce polyamines, which
support parasite growth. This detrimental activation
pathway was dependent on the parasite-induced activa-
tion of the transcription factor STAT6, but contrary to the
previously accepted paradigm, did not require (but was
amplified by) the presence of polarized Th2 cells or type 2
cytokines. Knockdown of host arginase or STAT6 enhanced
control of the infection, indicating that this activation
pathway has a critical role in the pathogenesis of the
disease. Interventions designed to inhibit the STAT6-
arginase-polyamine pathway could help in the treatment
or prevention of VL.
STAT6 and Arginase in Visceral Leishmaniasis
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Ethics statement
This study was carried out in strict accordance with the
recommendations in the Guide for the Care and Use of
Laboratory Animals of the National Institutes of Health. The
protocol was approved by the Institutional Animal Care and Use
Committee of the University of Texas Health Science Center at
San Antonio and the Institutional Animal Care and Use
Committee of the South Texas Veterans Health Care System.
Hamsters and mice
6-8 week old inbred Chester Beatty Syrian golden hamsters
(Mesocricetus auratus) were obtained from our own established
breeding colony at the South Texas Veterans Health Care System
Veterinary Medical Unit. 6-week old BALB/c mice were obtained
from Charles River Laboratories.
Isolation of primary macrophages and fibroblasts
Splenic macrophages were isolated from a spleen cell suspension
by adherence to plastic culture dishes. Resident peritoneal
macrophages were isolated from mice or hamsters by peritoneal
lavage with DMEM containing 2% heat-inactivated fetal calf
serum (HIFCS) and cultured in complete DMEM (DMEM plus
2mM glutamine, 1 mM Sodium pyruvate (Gibco), 1X MEM
aminoacids solution (Sigma), 50 mM b-mercaptoethanol, 10 mM
Hepes, 100 U/ml penicillin, and 100 mg/ml streptomycin) with
2–10% HIFCS. After overnight incubation, non-adherent cells
were removed and adherent cells cultured in complete DMEM
with 0.4% bovine serum albumin (BSA) or in Opti-MEM
(Invitrogen) plus 1% HIFCS for in vitro infections. Hamster
primary fibroblasts were obtained following the protocol described
to isolate mouse splenic primary fibroblasts [50]. In brief, spleens
were harvested from uninfected hamsters, treated with collagenase
D to obtain a single cell suspension, and cultured in RPMI 1640
containing 10% of heat inactivated FBS, 10 mM Hepes, 1 mM
sodium pyruvate (1 mm), 1X MEM aminoacids solution (Sigma),
100 IU/mL penicillin, 100 mg/mL streptomycin (Cellgro) and
50 mM 2-mercaptoethanol. The non-adherent cells were removed
at 24, 48 and 72 h of culture and the adherent cells were cultured
to reach confluence over 2 weeks. The fibroblast-like monolayer
was detached with Trypsin/EDTA and cultured overnight in
DMEM plus 2% FBS prior infection experiments. The purity of
the fibroblast population was determined to be .80% using PE
labeled-antibody against the ER-TR7 antigen (Santa Cruz) and
flow cytometry.
Parasites and infection
Leishmania donovani (MHOM/SD/001S-2D) promastigotes were
cultured as described previously [51]. Hamsters were infected by
intracardial injection and mice by intravenous injection of 10
6
peanut agglutinin purified metacyclic promastigotes [51] of a L.
donovani strain transfected with an episomal vector containing the
luciferase (luc) reporter gene [52]. The parasite burden was
measured in 100 mg of tissue homogenized in PBS and the
luminescent counts were transformed to number of parasites by
interpolation from a standard curve of luciferase activity and
number of amastigotes. For in vitro infections, stationary phase
promastigotes obtained from 5–6 day old cultures were either non-
opsonized, or opsonized with fresh, complement-containing
normal mouse or hamster serum (20% in DMEM), or freeze-
thawed hamster serum obtained from 6-week infected hamsters
(contained high titer of anti-Leishmania antibody) for 30 min at
37uC and 5% CO2, washed with PBS and used immediately to
infect the adherent primary macrophages or splenic fibroblasts, or
serum-starved (2% HIFCS) BHK fibroblast cells. Cells were
infected at a promastigote to host cell ratio of 10:1. Four hours
after the infection extracellular parasites were removed by
repeated (at least 3 times) washing with PBS and the infected
cells cultured thereafter in the low-serum medium described
above. For parasite burden determinations, the complete removal
of extracellular parasites was verified by microscopic inspection.
The level of infection after initial phagocytosis was assessed 4 hrs
after infection in Giemsa-stained preparations enumerated by
microscopy. Typically at 4 hrs post-infection there were 1–2
parasites per infected BHK cell (range 1 to 7) and .75% of cells
were infected. In experiments where parasite killing was assessed
an equivalent rate of initial (4 hr) infection was confirmed and the
parasite burden determined 4–72 hrs after infection by lumino-
metry.
Measurement of NOS2 and arginase enzymatic activity
and arginase protein expression
NOS2 activity (NO production) was estimated by the measure-
ment (Griess assay) of nitrites and nitrates in supernatants of
unstimulated cells or cells stimulated with IFN-c (10% v/v of
hamster recombinant IFN-c supernatants) plus 1 mg/mL lipopoly-
saccharide (LPS; E. coli serotype 0111:B4; Sigma) as described
previously [48,49]. The enzymatic activity of arginase was
determined in 100,000 adherent splenocytes [53], peritoneal
macrophages, or BHK fibroblasts cultured for 24–48 hrs in
complete DMEM supplemented with 0.4% BSA by measuring
the rate of urea formation from L-arginine in the presence of 1-
phenyl-1,2-propanedione-2-oxime (ISPF) [54,55]. Cells were stim-
ulated with IL-4 (10% v/v) and/or LPS (1 mg/mL), or infected with
L. donovani promastigotes or amastigotes. The measurement of
arginase activity in tissue samples homogenized in PBS (5 mg/mL)
was accomplished using the same method. Arg1 and GAPDH
protein expression were determined by western blot after separation
of 2 mg protein/lane from spleen homogenates and probing with
1 mg/mL goat anti-hamster arg1 polyclonal antibody or mouse
anti-glyceraldehyde-3-phosphate dehydrogensase (Clone 6C5,
Millipore) diluted 1:500 in 3% nonfat milk in TBS-T + 0.5M NaCl
and incubated at 4uC for 2 hours. After washing the membrane the
primary antibody was detected with HPRT-conjugated rabbit anti-
goat antibody diluted 1:20,000 in 5% BSA in TBS-T for 1.5 hrs at
room temperature. The anti-hamster arg1 antibody was produced
by Genemed Synthesis, Inc. (San Antonio, TX) by immunizing
goats with peptides (CFGTAREGNHKPGVDYLNNPPK and
CGLVEKLKETVYDVKDY) derived from the hamster arg1
deduced amino acid sequence. The antibody did not react with L.
donovani parasite lysates.
Determination of tissue and cellular polyamine content
Polyamines (putrescine, cadaverine, spermine, spermidine, N-
acetylspermine, and N-acetylspermidine) were quantified in acid-
extracted uninfected and infected hamster spleen, or uninfected
and in vitro infected macrophages using High Performance Liquid
Chromatography and fluorescence-based detection as described
[56–58].
Sequences of hamster and L. donovani cDNAs
The cDNAs of the hamster arg1 (GenBank Accession number
HM801029), arg2 (GenBank Accession number HM801027),
STAT6 (GenBank Accession number HM801028), and Leishmania
donovani arginase (GenBank Accession number DQ649412) were
cloned and sequenced as we have described previously [49,59].
STAT6 and Arginase in Visceral Leishmaniasis
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The expression of hamster and mouse mRNAs and L. donovani
arginase were determined in uninfected or infected tissue or cells by
real time RT-PCR. In brief, the extracted RNA (RNeasy, Quiagen)
was treated with DNAse (Turbo DNAse, Ambion), adjusted to 40–
100 ng/mL and reverse transcribed in a final volume of 20 mL( H i g h
capacity reverse transcription kit, Applied Biosystems). 2–40 ng of
reverse transcribed RNAwas amplified with400 nM of primers and
200 nM of Taqman probe in 15 mL of master mix (TaqMan,
Universal PCR Master Mix, Applied Biosystem). The sequences (59
to 39) of the primers and probes (59 6-FAM and 39 TAMRA
Quencher) used to detect the specific hamster or mouse cDNAs are
as follows: hamster and mouse arg1, forward, ACCTATGTGT-
CATTTGGGTGGA, reverse, GCAGATATGCAGGGAGT-
CACC, probe, TGCATGGGCAACCTGTGTCCTTTCT; ham-
ster and mouse arg2, forward, AGCCTGGCAATAGGTAC-
CATTA, reverse, TTCCAGATACAGTGGTGAGAGGT, probe,
CCGGCACCGCCCAGATCTC; Hamster NOS2, forward,
TGAGCCACTGAGTTCTCCTAAGG, reverse, TCCTATTT-
CAACTCCAAGATGTTCTG, probe, CGTGGACACTTCCT-
TTGTCTG TGCTCC; Mouse NOS2, forward, CCCAACAA-
TACAAGATGACCCTAA, reverse, TCCAGGGATTCTGGAA-
CATTCT, probe, ACCAAAATGGCTCCCCGCAGC; hamster
STAT6, forward, GAAGCACCACTTTGCAACACA, reverse,
GGCAGGTGACGGAACTCTTCT, probe, AGCTGGTGGC-
CACCATCAGACAAATAC; L. donovani arginase, forward, CGC-
GGACATCAACACTATGTCT, reverse, AAAGCACTCGGGA-
ATGTTCTTG, probe, CTTGCACGGCTGCCCCTTATCGA-
TC. The level of gene expression was determined by the
comparative threshold method using uninfected BHK-21 cells
(Syrian hamster fibroblast cell line) as a calibrator sample and the
18S ribosomal RNA (rRNA) gene (Applied Biosystems) as a
reference (normalizer) gene. Hamster cytokine mRNA expression
was determined as published [59].
Generation of recombinant hamster IL-4 and IFN-c
Hamster IL-4 was cloned [60] and inserted into the pMIB
expression vector (Invitrogen) and a stably-transfected line was
derived in insect SF9 cells with blastocidin selection. The
bioactivity of the recombinant protein in blastocidin-free SF9-
supernatants was confirmed using the STAT6-luciferase reporter
assay (see below) and the supernatants were used at 10% v/v
concentration. Recombinant hamster IFN-c was generated and
used to stimulate cells as described previously [48,49].
Measurement of STAT6 activation
Phospho-STAT6 was measured in resident peritoneal macro-
phages infected in vitro or in resident peritoneal macrophages
obtained from hamsters with VL. In brief, after lysis of the red
blood cells, macrophages were fixed with Phosflow fix buffer I
(BD), permeabilized with Phosflow perm buffer III (BD), washed
and blocked with 5% donkey serum, 2% BSA, and 0.05%
sodium azide in PBS, and incubated overnight at 4uC with rabbit
anti-human Phospho-STAT6 antibody (Tyr641, Cell Signaling)
or isotype controls diluted 1:100 in blocking buffer. After
washing, the cells were stained for 1 hr at room temperature
with the secondary antibody (Texas red labeled donkey anti-
Rabbit antibody) and the mean fluorescence intensity and
percentage of positive cells was determined by flow cytometry
(FacsAria, BD). The fluorescence of isotype controls from
infected and uninfected cells was used to determine the threshold
fluorescense.
STAT6 phosporylation was also determined by immunoprecip-
itation and western blotting. In brief, spleens were homogenized in
RIPA buffer with protease and phosphatase inhibitors (Santa
Cruz), the supernatants cleared with Protein A/G agarose (Santa
Cruz), and incubated at 4uC overnight with 1 mgo fa n t i - S T A T 6
polyclonal antibody (M-20, Santa Cruz). The STAT6/antibody
complex was then immunoprecipitated with Protein A/G
agarose, the protein released from the beads by heating at
95uC, and resolved by SDS-PAGE and transferred to nitrocel-
lulose membranes. Blots were blocked with 5% BSA in TBS-T
and incubated overnight at 4uCw i t h1mg/mL of anti-phospho
STAT6 antibody (Cell Signaling). After washing, the primary
antibody was detected with HRP-conjugated anti-rabbit second-
ary antibody (Cell Signaling) and substrate (West Pico, Thermo
Scientific) followed by chemiluminescent detection (ECL;
Amersham). GAPDH expression was determined as described
above.
STAT6 activation was measured by a reporter assay using the
BHK-21 cell line transfected with the luciferase reporter plasmid
p(IE-IL4RE)4-LUC (a generous gift from Dr. Michael Berton,
University of Texas Health Science Center, San Antonio, TX) that
included 4 copies of a consensus STAT6 response element
sequence. The p(IE-IL4RE)4-LUC reporter plasmid was initially
used to determine the STAT6 domains required for IL-4-induced
transcription [61] and has since been used extensively as a reporter
for IL-4 induced STAT6 activation. The BHK-21 [IL-4RE]4 LUC
cell line was regularly maintained and sub-cultured every 72 h in
DMEM with 10% HIFCS and 2 mg/mL puromycin. When cells
were to be infected they were cultured overnight in complete
DMEM with 2% HIFCS without puromycin, seeded in 96-clear-
bottom white plates (25,000/well), and infected at 10:1 para-
site:cell ratio using opsonized L. donovani promastigotes. After 4 hr
of infection, excess extracellular parasites were removed and the
infected cells cultured in complete DMEM with 2% HIFCS. The
STAT-6 reporter activity was determined by luminometry using
20 mL of 1X lysis buffer and 80 mL of luciferin substrate from
Promega.
Knock down STAT-6 and arg1 by miRNAi
The expression of STAT6 and arg1 genes was knocked down
using a vector-based approach. miRNAi inserts targeting the
hamster STAT6 or arg1 sequences and containing the structural
features of the pre-miRNA, were designed using the BLOCK-iT
RNAi Designer program (Invitrogen) as follows: hamster arg1, top,
TGCTGTGTATCAGCTGACTAT CATG TGTTTTGGCC-
ACTGACTGACACATGATACAGCTGATACA, bottom, CCT
GTGTATC AGCTGTATCATGTGTCAGTCAGTGGCCAA-
AA CACATGATAGTCA GCTGATACAC; hamster STAT6,
top, TGCTGAACAGGATCTCCTTGTTGAA CGTTTTGG-
CCACTG ACTGACGTTCAACAGAGATCCTGTT, bottom,
CCTG AACAGGATCTCTGTTGAA CGTCAGTCAGTGGC-
CAAAACGTTCAACAAGGAGATCCTGTTC. dsOligos were
generated and cloned into pcDNA 6.2-GW/6EmGFP-miR
according the manufacturer instruction (Block-it PolII miR RNAi
Expression Vector kits, Version E, Invitrogen). The expression
vector was purified with PureLink HiPure Plasmid DNA
purification kit (Invitrogen) and transfected in low passage BHK-
21 cells (obtained from ATCC; 150,000 cells per well/500 mLi n
24 well plates) using 0.8 mg of plasmid and 1 mL of Lipofectamine
2000 in OptiMem (InVitrogen) as recommended in the instruction
manuals. The pcDNA 6.2-GW/6EmGFP-miR-LacZ plasmid
(Invitrogen), which expresses an irrelevant target sequence was
used as a control in all the miRNAi experiments. The transfected
cells were selected after 24 hr in DMEM with 10% HIFCS and
20 mg/ml of Blasticidin, and after 15 days of selection the stably
transfected cells were cloned by limiting dilution and screened for
STAT6 and Arginase in Visceral Leishmaniasis
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selected cells were expanded and the efficiency of gene knockdown
was determined at the mRNA level by real time RT-PCR and at
the protein level by western blot. STAT6- and arg1-knockdown
cells were transferred to 12-well plates (250,000 cells/1 mL
DMEM with 2% HIFCS and 20 mg/ml of blasticidin) and
infected for 4h with 1:10 L. donovani opsonized promastigotes as
above. The parasite burden was determined in equal numbers of
cells at the specific time points by luminometry.
Statistical analyses
Comparison between experimental groups was performed using
one-way ANOVA. A parametric or non-parametric test was
selected according the distribution of the raw data, followed by a
post-test analysis for multiple groups as appropriate. All analyses
were conducted using GraphPad InStat version 3.00 software for
Windows 95 (GraphPad Software, San Diego California USA).
Results
Dominant expression of arg1 during progressive VL
Systemic infection of hamsters with L. donovani resulted in
progressive, lethal VL [47–49]. This contrasted sharply with L.
donovani infection in the mouse, which did not cause lethal disease
and had a significantly lower parasite burden compared to
hamsters infected with the same number of parasites (Fig. 1A). We
demonstrated previously that in the hamster model of VL, there
was impaired macrophage activation and parasite killing [49].
This was accompanied by transcriptionally-mediated low NOS2
expression and NO production in the infected hamster compared
to the infected mouse ([48,49] and Fig. 1B). We hypothesized that
the low NO production would favor default toward an arginase-
dominated metabolism of arginine at the site of infection. Indeed,
the low expression of NOS2 in the hamster spleen was
accompanied by high splenic arginase activity, measured by
Figure 1. Dominant expression of arg1 in spleen tissue during progressive visceral leishmaniasis. A) Parasite burden in the spleens of
hamsters and mice (n=6 per group) infected with L. donovani-Luc for 6 weeks. The mean and standard deviation (SD) of the parasite burden,
determined by luminometry and interpolation from a standard curve generated by enumeration and luciferase assay of amastigotes from the same
tissue, is shown from a single experiment that is representative of 3 independent experiments. B) Expression of NOS2 mRNA in spleens of uninfected
(Un) and 6-week L. donovani infected (Inf) mice and hamsters (n=6 per group). The mean and standard error of the mean (SEM) of the fold-increase
of NOS2 mRNA relative to BHK cells, determined by real time RT-PCR in 2 experiments is shown. C) Arginase activity in spleens of uninfected (Un) and
6-week L. donovani infected (Inf) mice and hamsters (n=6 per group). The mean and standard deviation (error bars) of the tissue arginase activity,
determined by assay of urea production, is shown from a single experiment that is representative of 3 independent experiments. D) Expression of
arg1 mRNA in spleens of uninfected (Un) and 4-week L. donovani infected (Inf) mice and hamsters. The mean and standard deviation (error bars) of
the fold-increase of arg1 mRNA relative to BHK cells, determined by real time RT-PCR in groups of 7 animals, is shown from a single experiment that is
representative of 2 independent experiments. E) Expression of L. donovani arginase mRNA in spleens of 4-week L. donovani infected mice and
hamsters. The mean and standard deviation (error bars) of the fold-increase of L. donovani arg1 mRNA relative to BHK cells, determined by real time
RT-PCR in groups of 7 animals, is shown from a single experiment that is representative of 2 independent experiments. F) Log10 ratio of hamster arg1
mRNA to L. donovani arginase mRNA (open bars) and log10 ratio of hamster arg1 mRNA to hamster NOS2 mRNA (filled bars) in the spleens of 4-week
L. donovani infected mice and hamsters. The mRNA expression was determined by real time RT-PCR in groups of 7 animals and used to calculate the
mean and SD of the log ratios. The ratios were calculated from the raw data shown in Figs. 1B, 1D, and 1E. The statistical significance of differences in
each of the panels is identified by asterisks (** p,0.01; ***, p,0.001).
doi:10.1371/journal.ppat.1002417.g001
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pattern of high arginase activity/NOS2 expression was reversed in
the infected mouse spleen (Figs. 1B and 1C).
To determine the source of the increased arginase activity we
first analyzed the expression of parasite and host arginase mRNAs.
We cloned the hamster arg1 and arg2 cDNAs and the L. donovani
arginase cDNA and measured expression of these cDNAs by real
time RT-PCR because the biochemical measurement of arginase
did not discriminate between the mammalian isoforms and
parasite arginase. Hamster arg2 expression was not increased in
infected compared to normal tissue (see Fig. 2D), but there was a
striking increase in hamster arg1 mRNA in the spleens of hamsters
with progressive VL compared to uninfected hamsters and
uninfected or infected mice (Fig. 1D). Additionally, infection did
not upregulate splenic arg1 mRNA expression in mice (Fig. 1D).
The expression of L. donovani arginase transcripts paralleled the
Figure 2. Kinetics of arginase expression in spleen tissue during progressive visceral leishmaniasis. A) Parasite burden in the spleens of
hamsters (n=6 per group) infected with L. donovani for 14, 28, 42, and 56 days. The mean and SEM (error bars) of the parasite burden, determined by
luminometry and interpolation from an amastigote standard curve, is shown from a single experiment that is representative of 2 independent
experiments. B) Arginase activity in the serum (open bars) and spleen tissue (filled bars) of uninfected hamsters (Day 0) and hamsters infected with L.
donovani (n=6 per group) for 7, 14, 28, 42, and 56 days. The mean and SD of the tissue arginase activity, determined by assay of urea production, is
shown. C) Hamster arg1 protein expression determined by western blot in spleens of control hamsters (0 days post-infection) and hamsters infected
with L. donovani for 7, 14, and 28 days. The expression of GAPDH is shown as a control for protein loading. Each lane contains splenic lysate from a
single hamster, with two lanes per time point. The anti-arginase antibody did not react with parasite arginase by immunoblot. D) Time course of
expression of hamster arg1 mRNA (filled bars), L. donovani arginase mRNA (empty bars), hamster NOS2 (iNOS) mRNA (hatched bars), and hamster
arg2 mRNA (hatched bars) in spleens of control hamsters (0 days post-infection) and hamsters infected with L. donovani for 7, 14, 28, 42, and 56 days.
The mean and standard deviation (error bars) of the fold-increase of arginase mRNA relative to BHK cells, determined by real time RT-PCR in groups of
6 animals, is shown from a single experiment that is representative of 3 independent experiments. The statistical significance of differences in eacho f
the panels is identified by asterisks (*, p,0.05; **, p,0.01; ***, p,0.001).
doi:10.1371/journal.ppat.1002417.g002
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but was a relatively minor contributor to the overall expression of
arginase in hamsters (Fig. 1F; Fig. 2B). When the expression of
parasite arginase and host NOS2 was compared to host arg1 a
striking difference between mice and hamsters was evident. The
level of hamster arg1 was more than 1000-fold greater than the
level of parasite arginase in infected spleen tissue, whereas the ratio
was inverted in the infected mouse spleen with parasite arginase
being greater than host arg1 expression (Fig. 1F, open bars).
Similarly, the host arg1 to NOS2 ratio was high in the infected
hamster spleen, but the ratio was reversed in the infected mouse
spleen (Fig. 1F, filled bars).
Kinetics studies revealed a sharp increase in the visceral parasite
burden of L. donovani infected hamsters relatively late in the
course of infection (Fig. 2A) that was accompanied by increased
arginase activity in the serum and spleen (Fig. 2B). Dramatically
increased expression of arg1 protein (Fig. 2C) and mRNA (Fig. 2D)
was also evident in the spleen of infected hamsters. Unexpectedly,
we found discordance between the level of hamster arg1 mRNA
expression and arg1 protein expression and arginase enzyme
activity late in the course of infection; after the peak at 28 days
post-infection, the mRNA expression decreased but the level of
protein and enzyme activity remained high. Hamster arg2 mRNA
was not expressed in the spleen throughout the course of infection,
and hamster NOS2 mRNA was increased only slightly at day-56
of infection (Fig. 2D).
Several polyamines are end-products of arginine metabolism
throughtheactionofarginase andornithinedecarboxylase[56–58].
Weconfirmed the downstreameffectofincreasedarg1 expressionin
hamsters with VL by demonstrating increased putrescine and
spermidine in infected compared to uninfected spleen tissue
(Fig. 3A), and increased putrescine, spermine, and spermidine in
the infected liver (Fig. 3B). In infected hamsters there was no
increase in the tissue content of acetylspermine and acetylspermi-
dine, or cadaverine, which is a product of lysine metabolism. The
tissue polyamine content in the spleen and liver of mice was
relatively low compared to the hamster tissue, and it was not
increased in infected compared to uninfected mice (Fig. S1).
Cytokines that promote alternative macrophage
activation are upregulated late in the course of VL
The dominant expression of hamster arg1 in progressive VL
suggested that IL-4, IL-10, IL-13, or IL-21, or a combination of
t h e s ec y t o k i n e s ,w h i c ha r ek n o w nt op r o m o t ea l t e r n a t i v e
macrophage activation (reviewed in [36]), might be driving
t h ee x p r e s s i o no fa r g 1 .S i n c et h et y p e2c y t o k i n e si n d u c e
arginase expression through a STAT6-dependent pathway, we
first investigated whether there was evidence of STAT6-
inducing activity in the serum and spleens of hamsters with
VL. Using a STAT6 reporter assay, we found that there was a
significant increase in STAT6-inducing activity in the serum
(56% increase; p,0.05) obtained from hamsters with active VL
(56 days post-infection) compared to uninfected controls. These
findings led us to consider that the type 2 cytokines might
contribute to the increased expression of arg1 in VL. After
systemic infection with L. donovani, a relatively silent phase
during the first ,3 weeks of infection was followed by increased
expression of IL-4, IL-10, IL-13, and IL-21 (Fig. 4). The
increase in these cytokines was coincident with, but did not
appear to precede, the dramatic increase in parasite burden and
arginase activity (see Figs. 2 and 5A).
L. donovani induces arg1 expression in infected
macrophages
The increase in splenic arginase activity over the course of
infection was paralleled by a similar increase in arginase activity in
macrophages isolated from the spleens of hamsters infected with L.
donovani (Fig. 5A). The reciprocal expression of arg1 and NOS2
mRNAs was also observed in splenic macrophages isolated from
infected mice and hamsters. Splenic macrophages isolated from 4-
week infected hamsters had a high arg1 to NOS2 ratio, but this
ratio was reversed in splenic macrophages isolated from 4-week
infected mice (Fig. 5B). Furthermore, resident peritoneal macro-
phages from hamsters with VL showed increased arginase activity
compared to peritoneal macrophages from uninfected animals, but
arginase activity in peritoneal macrophages from mice infected
with the same number of parasites was not increased (Fig. 5C). An
increase in L. donovani-induced arginase activity (Fig. 5D) and arg1
mRNA (Fig. 5E) was also evident in hamster peritoneal
macrophages infected in vitro with L. donovani promastigotes.
Opsonization of L. donovani promastigotes with either fresh hamster
serum containing complement or hamster serum containing anti-
Leishmania antibodies did not influence the parasite-mediated
induction of arginase activity (Fig. 5D). Congruent with the
findings of increase polyamine synthesis in infected hamster tissues
(see Fig. 3), the downstream effect of the increased arginase activity
Figure 3. Polyamine content in spleen and liver tissue in L. donovani infected hamsters. The concentration of polyamines in spleen (A) and
liver (B) tissue samples from groups of 6 uninfected hamsters (open bars) and 56 day infected hamsters (filled bars) is expressed as the mean and SD
(error bars) of nmol polyamine per mg protein. The data shown are from a single experiment that is representative of 2 independent experiments.
The statistical significance of differences in each of the panels is identified by an asterisk (*, p,0.05).
doi:10.1371/journal.ppat.1002417.g003
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polyamine (putrescine, spermidine, and spermine) synthesis
compared to uninfected cells (Fig. 5F).
Parasite-induced arg1 requires de novo protein synthesis
but not parasite internalization
We next determined if de novo protein synthesis was required for
the parasite-induced increase in arg1 mRNA. To do this we
established an in vitro infection model in the BHK hamster
fibroblast cell line, since primary macrophages were killed by the
protein synthesis inhibitor cycloheximide, even at very low doses,
and no hamster macrophage cell lines were available. We first
demonstrated that, like hamster macrophages (Fig. 5D), hamster
primary splenic fibroblasts expressed arg1 in response to in vitro
infection with L. donovani (Fig. 6A). Furthermore, we showed that
BHK fibroblasts could be infected with L. donovani (confirmed by
microscopical examination and co-localization with phagolysoso-
mal staining; see Fig. S2), and were capable of metabolizing
arginine through either the NOS2 or arginase pathways. BHK
fibroblasts generated NO in response to classical activation stimuli
(IFN-c/LPS) and expressed arginase activity in response to LPS as
was described for macrophages from murine rodents[62] (Fig. 6B).
Surprisingly, IL-4 alone did not induce arginase activity in BHK
fibroblasts. We next showed that like hamster macrophages, in
vitro infection of BHK fibroblasts resulted in parasite-induced
arg1 mRNA expression (Fig. 6C). The parasite-induced arg1
expression was amplified by concomitant exposure to exogenous
recombinant hamster IL-4 (Fig. 6C). The induction of arg1
expression was also evident in BHK cells infected with spleen-
derived purified amastigotes (Fig. 6D). Dose titration studies
Figure 4. Kinetics of cytokine expression in spleen tissue during progressive visceral leishmaniasis. Expression of hamster IL-4 (A), IL-10
(B), IL-13 (C), and IL-21 (D) mRNAs in the spleens of control hamsters (0 days post-infection) and hamsters infected with L. donovani for 7, 14, 28, 42,
and 56 days. The mean and standard deviation (error bars) of the fold-increase of cytokine mRNA relative to BHK cells, determined by real time RT-
PCR in groups of 6 animals, is shown from a single experiment that is representative of 2 independent experiments. The statistical significance of
differences in each of the panels is identified by asterisks (*, p,0.05; **, p,0.01; ***, p,0.001).
doi:10.1371/journal.ppat.1002417.g004
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protein synthesis but did not significantly reduce cell viability in
BHK cells. Parasite-induced arg1 transcription was blocked by
non-toxic concentrations of cycloheximide (CHX) when the CHX
was present during the first 12 hrs of exposure to the Leishmania
(Fig. 6E), indicating that early de novo synthesis of either an
autocrine or paracrine protein, was required for arg1 mRNA
expression. However, infected BHK cells did not express IL-4
mRNA (by real-time RT-PCR the CT value for GAPDH was
22.960.09 and the CT value for IL-4 was below the threshold limit
of detection), and expressed very low basal levels of IL-13 that did
not increase with infection (after correction for GAPDH
expression the fold-increase relative to the BHK calibrator was
1.14 6 0.16 for uninfected cells and 0.9860.2 for infected cells;
p=0.16), suggesting that the parasite-induced arg1 expression was
independent of type 2 cytokine synthesis. The parasite-induced
transcription of arg1 did not require the internalization of
parasites, since separation of promastigotes from hamster cells
with a 0.4 m membrane did not abrogate the parasite-induced
increase in arg1 mRNA expression (Fig. 6F).
Figure 5. Arg1 expression and polyamine content in L. donovani infected macrophages. A) Arginase activity in macrophages isolated by
adherence from single-cell suspensions from the spleens of control hamsters (0 days post-infection) and hamsters infected with L. donovani for 7, 14,
21, 42, and 56 days. The mean and SD (error bars) of the arginase activity in 100,000 cells, determined by assay of urea production, is shown from a
single experiment that is representative of 2 independent experiments. B) Log10 ratio of host arg1 to NOS2 mRNA in splenic macrophages of 4-week
L. donovani infected mice and hamsters. The mRNA expression was determined by real time RT-PCR in groups of 5 animals and used to calculate the
log ratios, shown as the mean and SD (error bars) from a single experiment that is representative of 2 independent experiments. The ratios were
determined from the following raw data: Arg1 mRNA fold-increase with reference to the BHK cell calibrator (mean 6 SD): uninfected mice, 5.765.9;
uninfected hamster, 3,36762,858, infected mice, 8.5610; infected hamster, 131,984656,407; iNOS mRNA fold-increase with reference to BHK cell
calibrator (mean 6 SD): uninfected mice, 133.346182.4; uninfected hamster, 1.0360.3, infected mice, 2,98464,535; infected hamster, 19.56610.87).
C) Arginase activity in peritoneal macrophages isolated from mice and hamsters that were uninfected (open bars) or infected in vitro with L. donovani
for 48 hrs (filled bars). The mean and SD (error bars) of the arginase activity, determined by assay of urea production, is shown from a single
experiment that is representative of 2 independent experiments. D) Arginase activity in hamster peritoneal macrophages that were uninfected (Un)
or infected in vitro with L. donovani (1:5 macrophage:parasite ratio). Parasites were either unopsonized (None), opsonized with normal fresh
complement-containing hamster serum (Comp), or opsonized with freeze-thawed hamster serum containing anti-Leishmania antibody (Ab). The
mean and standard deviation (error bars) of the arginase activity in 200,000 cells of 6 different samples determined by assay of urea production, is
shown from a single experiment that is representative of 2 experiments. Statistical comparisons are made to the control group. E) Expression of
hamster arginase mRNA in hamster peritoneal macrophages that were uninfected (Un) or infected in vitro with L. donovani stationary-phase
promastigotes for 24 hrs (Inf). The mean and SEM (error bars) of the fold-increase of arg1 mRNA relative to BHK cells, determined by real time RT-PCR
in groups of 6 samples per experiment, is shown as data pooled from 4 independent experiments. F) The concentration of polyamines in uninfected
(open bars) and 48-hour in vitro infected hamster peritoneal macrophages (filled bars) (n=6 per group) is expressed as the mean and SD (error bars)
of nmol polyamine per mg protein. The data shown are from a single experiment that is representative of 2 independent experiments. The statistical
significance of differences in each of the panels is identified by asterisks (*, p,0.05; **, p,0.01; ***, p,0.001).
doi:10.1371/journal.ppat.1002417.g005
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PLoS Pathogens | www.plospathogens.org 9 January 2012 | Volume 8 | Issue 1 | e1002417Figure 6. Parasite-induced host arg1 expression impairs macrophage anti-leishmanial activity. A) Expression of hamster arginase mRNA
in primary hamster splenic fibroblasts that were uninfected (Un) or infected in vitro with L. donovani stationary-phase promastigotes for 24 hrs (Inf).
The mean and standard deviation (error bars) of the fold-increase of arg1 mRNA relative to normal BHK cells, determined by real time RT-PCR in
groups of 6 animals, is shown from data pooled from 3 independent experiments. B) Arginase activity and NO production in BHK fibroblasts. Arginase
activity was determined stimulated with IL-4 or IFN- c respectively. Arginase activity was determined in BHK cells that were unstimulated (Uns) or
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without enhanced NO production
Since arginase and NOS2 compete for the same substrate,
arginine, we reasoned that inhibition of arginase might reverse the
low NO production observed in activated hamster macrophages
and lead to enhanced parasite killing. Treatment with the arginase
inhibitor norNOHA resulted in a significant dose-dependent
reduction in arginase activity (Fig. S3, panel A) and parasite
burden (Fig. S3, panel B) in peritoneal macrophages infected in
vitro, and a reduction in parasite burden in ex vivo cultured spleen
cells isolated from infected hamsters (Fig. S3, panel C). However,
we found that norNOHA demonstrated a dose-dependent killing
of amastigotes purified from infected hamster spleens (Fig. S3,
panel D) and axenically cultured L. donovani promastigotes (Fig. S3,
panel E), suggesting that it was inhibiting parasite arginase.
Therefore, to investigate the role of arginase in parasite replication
without the potential confounding influence of parasite arginase
activity, we used the BHK infection model to knockdown host
arg1. Transfection of BHK cells with an arg1-specific miRNAi
vector resulted in .90% reduction in arg1 mRNA expression
(p=0.002) and reduction of arg1 protein to a level undetectable by
western blot (Fig. 6G). L. donovani infected BHK cells that
expressed the arg1-specific miRNAi vector were found to have
an equivalent parasite burden at 4 and 24 hrs post-infection but
significantly reduced parasite burden at 48 hrs (p,0.01) and
72 hrs (p,0.001) post-infection compared to non-transfected cells
or cells transfected with a non-targeting miRNAi construct
(Fig. 6H). The approximately 50% decrease in parasite burden
following arg1 knockdown suggests that either there is residual
arginase expression (undetectable by western blot) that is sufficient
to promote some parasite survival, or more likely that arginase is
not the only determinant of parasite survival and replication in this
model. This enhancement of parasite killing by knockdown of arg1
in BHK cells was not accompanied by greater parasite-induced
NO production (Fig. 6I), even though BHK cells were fully
capable of generating NO (see Fig. 5B). Thus it would appear that
parasite-induced macrophage arg1 contributes to L. donovani
replication through mechanisms other than reduction of NO
production.
STAT6 activation drives parasite-induced arg1 expression
in VL
The expression of phosphorylated STAT6 was increased in the
spleen tissue of hamsters over the course of in vivo infection with L.
donovani (Fig. 7A). To dissect the role of STAT6 in L. donovani-
induced arg1 expression we used the in vitro infection model of the
BHK hamster fibroblast cell line as described above. Using an in
vitro reporter assay we found that exposure of hamster fibroblasts
to metacyclic L. donovani promastigotes activated STAT6 in a dose-
dependent manner (Fig. 7B). The STAT6 activation was not
influenced by parasite opsonization with complement-containing
serum (Fig. S4). Parasite-induced STAT6 phosphorylation was
further confirmed by flow cytometry in infected BHK cells
(Figs. 7C and 7D), in splenic macrophages isolated from hamsters
with VL (Fig. 7E), and in hamster peritoneal macrophages infected
in vitro with L. donovani promastigotes (Fig. 7F). The percent of
macrophages that showed parasite-induced STAT-6 phosphory-
lation was relatively lower than the percent positive activated by
IL-4 (Fig. 7D). Knockdown of hamster STAT6 in BHK cells using
miRNAi resulted .90% decrease in mRNA expression (Fig. 7G)
and reduction of STAT6 protein to a level undetectable by
western blot (Fig. 7H). The significance of parasite-induced
STAT6 activation was confirmed by showing a 92% reduction
in arg1 mRNA expression when STAT6 was knocked-down
(similar to the reduction obtained with arg1-specific knockdown)
compared to a control non-targeting miRNAi (p,0.001; Fig. 7G)
and enhanced control of intracellular parasite replication in BHK
cells (equivalent infection after 4 hrs but significantly reduced
parasite burden at 24, 48, and 72 hrs post-infection compared to
non-transfected cells or cells transfected with a non-targeting
miRNAi construct (p=0.001; Fig. 7H). Collectively, these data
indicate that parasite-induced STAT6 activation drives expression
stimulated for 48h with IL-4 (10% v/v), LPS (1 mg/mL), or both. The mean and standard deviation (error bars) of the arginase activity of 6 different
stimulated samples compared to that of non stimulated cells determined by assay of urea production, is shown from a single experiment that is
representative of 2 experiments. NO production was estimated by the measurement of nitrites + nitrates in supernatants of unstimulated cells (Uns)
and cells stimulated with IFN-c (10% v/v of hamster recombinant IFN-c supernatants) plus 1 mg/mL LPS for 48h. The mean and standard deviation
(error bars) of the nitrites/nitrates of 6 different samples determined by Griess assay is shown from a single experiment that is representative of 2
experiments. C) Expression of hamster arginase mRNA in hamster BHK cells that were uninfected (Un) or infected in vitro with L. donovani stationary-
phase promastigotes for 24 hrs (Inf) and cultured with or without recombinant hamster IL-4 (10% v/v supernatant) or sham supernatant. The mean
and standard deviation (error bars) of the fold-increase of arg1 mRNA relative to BHK cells, determined by real time RT-PCR in groups of 6 animals, is
shown from data pooled from 3 independent experiments. D) Expression of hamster arginase mRNA in hamster BHK fibroblasts that were uninfected
(Un) or infected in vitro with L. donovani tissue-derived amastigotes for 24 hrs (Inf). The mean and standard deviation (error bars) of the fold-increase
of arg1 mRNA relative to BHK cells, determined by real time RT-PCR in groups of 6 animals, is shown from data pooled from 2 independent
experiments. E) Effect of cycloheximide (CHX) on parasite-induced hamster arg1 mRNA expression in BHK cells was determined by exposing cells to
CHX (20 mg/mL) early (4–12 hrs) and/or late (12–24 hrs) during a 24-hr L. donovani infection. The mean and SD (error bars) of the fold-increase of arg1
mRNA relative to BHK cells, determined by real time RT-PCR in groups of 6 samples, is shown from data from a single experiment that is
representative of 2 independent experiments. F) Induction of expression of hamster arg1 in peritoneal macrophages by soluble parasite factors was
determined by culturing hamster peritoneal macrophages with stationary phase promastigotes (1:10 ratio) separated by a 0.4 m pore size membrane
(Falcon). The mean and SEM (error bars) of the fold-increase of arg1 mRNA relative to BHK cells, determined by real time RT-PCR in groups of 6
animals, is shown from data pooled from 3 independent experiments. G) miRNAi-mediated arg1 knockdown in BHK cells. Arg1 protein in BHK cells
stably transfected with a miRNAi vector targeting arg1 (Arg-1 KD) or stably transfected with a miRNAi vector coding a control sequence (Control)
determined by Western blot using a specific polyclonal antibody raised against hamster arg1. Representative of 2 different blots. H) Effect of miRNAi-
mediated knockdown on parasite burden was determined in BHK cells that were transfected with a non-targeting miRNAi vector (control) or a vector
specific to hamster arg1. The transfected cells were infected with L. donovani metacyclic promastigotes and the mean and standard deviation (error
bars) of the parasite burden at 4, 24, 48 and 72 hrs post-infection, determined by luminometry, is shown from a single experiment that is
representative of 2 independent experiments. There was no difference in parasite burden between the two groups at 4 and 24 hrs post-infection. I)
Arg1 knockdown did not induce NO production in BHK cells infected with L. donovani. NO production in BHK cells stably transfected with a miRNAi
vector targeting Arg1 (Arg1 knockdown) or transfected with an irrelevant miRNAi vector (Non targeted). The mean and standard deviation (error bars)
of the nitrites/nitrates released in the supernatant of cells after 48h infection with L. donovani was determined by Griess assay. Data are from a single
experiment that is representative of 3 independent experiments. (**p,0.001). The statistical significance of differences in each of the panels is
identified by asterisks (*, p,0.05; **, p,0.01; ***, p,0.001).
doi:10.1371/journal.ppat.1002417.g006
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PLoS Pathogens | www.plospathogens.org 11 January 2012 | Volume 8 | Issue 1 | e1002417Figure 7. Role of parasite-induced STAT6 activation in host arg1 expression and L. donovani infection. A) Phosphorylated STAT6 in
spleens of hamsters infected with L. donovani determined by immunoprecipitation followed by western blot of whole splenic lysates. The samples
(before immunoprecipation) were probed with anti-STAT6 anti-GAPDH antibodies to confirm equivalent protein loading. The blot shown is from
tissue from a single animal, representative of 4 independent experiments. B) Dose-dependent induction of STAT6 activation by L. donovani in BHK
cells transfected with a STAT6-luciferase reported vector. Data are presented as the mean and standard deviation (error bars) of the relative light units
in uninfected (0 parasites) cells and cells exposed to 1–40 parasites per cell over 48 hrs of culture. Shown is data from a single experiment that is
representative of 2 independent experiments. C-D) Phosphorylation of STAT6 in hamster peritoneal macrophages exposed to L. donovani (10
parasites per cell) or IL-4 (10% v/v supernatants) measured as fold-increase of mean fluorescence intensity (MFI) (C) or percent positive cells (D)b y
flow cytometry. Data are presented as the mean and standard deviation (error bars) and are from a single experiment that is representative of 2
independent experiments. E–F) Phosphorylation of STAT6 in hamster BHK cells exposed to L. donovani (10 parasites per cell) measured as fold-
increase of mean fluorescence intensity (MFI) (E) or percent positive cells (F) by flow cytometry. Data are presented as the mean and standard
deviation (error bars) and are from a single experiment that is representative of 2 independent experiments. G) Effect of miRNAi-mediated STAT6
STAT6 and Arginase in Visceral Leishmaniasis
PLoS Pathogens | www.plospathogens.org 12 January 2012 | Volume 8 | Issue 1 | e1002417of host arg1, which in turn contributes to intracellular parasite
replication and/or survival.
Discussion
We initiated these studies because there is a deficit in our
understanding of the molecular and cellular determinants
underlying the pathogenesis of VL. We used a hamster model of
VL because the clinicopathological features of this model closely
mimic active human VL, and insights gained from this model may
enhance our understanding of the immunopathogenesis of human
disease. In the studies we present here we identified a program of
alternative macrophage activation that is evident in the spleens of
hamsters with VL, and in L. donovani infected macrophages.
Characteristic of this phenotype is the dominant expression of host
arg1 over NOS2 in infected hamster spleen tissue and macro-
phages. Here we show that L. donovani induces host arg1 expression
through a mechanism that involves parasite-induced STAT6
activation, but different from the prevailing paradigm of
alternative activation in cutaneous leishmaniasis [42–44], occurs
even in the absence of a polarized type 2 cytokine response.
The tissue-level dominance of arginase over NOS2-mediated
arginine metabolism is driven by increased host arg1 but not arg2
transcription. Furthermore, hamster arg1, which is expressed by
macrophages in the infected spleen, is dominant over the level of
parasite arginase even though parasite arginase expression
increases throughout the course of infection. This contrasts
sharply with what we found in the murine model of non-
progressive L. donovani infection where host arg1 expression is not
dominant, and parasite arginase appears to have a relatively
greater contribution to the total arginase activity. Similarly, in the
murine model of L. major infection, parasite arginase contributes
significantly to the overall cellular arginase activity [63]. While it is
logical that L. donovani arginase contributes to the pathogenesis of
VL, our data suggest that it has a significantly lesser role than host
arg1. Quantification of its contribution to the pathogenesis of VL
in this model will require studies using an enzyme inhibitor
selective for parasite arginase or arginase-deficient parasites.
The consequences and significance of the increased host arg1
expression in the progression of VL is underscored by several
findings. First, during progressive infection there was an increase
in tissue polyamines, which are end products of arginase- and
ornithine decarboxylase-mediated metabolism of arginine. Poly-
amines, synthesized by the parasite or scavenged from host cells
through uptake receptors [45], promote Leishmania growth [46].
The importance of polyamines is underscored by their critical role
in the growth of a number of other protozoa, including
Trypanosoma brucei, T. cruzi, Toxoplasma and Plasmodium [64–66].
Second, the increase in host arg1 transcription and enzyme
activity paralleled the increase in the visceral parasite burden. This
corroborates the findings in the murine model of L. major infection
[42–44]. However, late in the course of hamster VL there is a
relative decrease in the expression of arg1 mRNA but sustained
arginase protein expression and enzyme activity, which is
consistent with the previous notion that arg1 is also post-
transcriptionally regulated [67]. Third, as noted above, we found
that at the site of visceral infection (spleen) in hamsters there is
dominant expression of arg1, such that the arg1 to NOS2 ratio in
hamsters with progressive disease was thousands-fold greater than
the ratio observed in mice, which are able to control the infection.
The non-induced arg1 mRNA expression in the L. donovani
infected mouse spleen in our study was different from the 4.8-fold
increase reported in a recent study [68]. This difference may be
due in part to infection with a different L. donovani strain (Indian vs.
East African) and use of a much larger inoculum in the study by
Biswas, et al. [68]. Nevertheless, the expression of arg1 in the L.
donovani infected mouse is dramatically less than the increase
observed in the hamster model of progressive VL. This dominant
expression of arg1 in hamster VL lead to disease by production of
parasite-promoting polyamines, or by driving arginine metabolism
away from NOS2 and production of the anti-leishmanial effector
molecule NO (which is already expressed at a low level). Fourth,
and most significantly, targeted knockdown of host arg1 mRNA
led to enhanced capacity to control intracellular parasite
replication. Although other investigators demonstrated that
chemical inhibition of arginase enhanced control of Leishmania
infection [42,44], we found that the arginase inhibitor nor-NOHA
mediated a host-independent anti-parasitic effect, presumably by
direct inhibition of parasite arginase (which was also recently
demonstrated for L. mexicana arginase [69]), and therefore could
not be used to distinguish an effect of host arginase independent of
parasite arginase in our model. This increased control of infection
mediated by targeted arg1 knockdown did not appear to be driven
by enhanced production of NO by the isolated infected
macrophage, suggesting that the parasite-induced arginase has a
pathological effect through the increase in polyamines that
promote parasite growth. This is consistent with the findings in
L. major infection [44].
As stated previously, alternatively activated macrophages, as
introduced by Gordon and colleagues, display a unique phenotype
when activated in the presence of IL-4 or IL-13 [36,37]. The gene
expression profile of these macrophages includes reduced
expression of NOS2, and increased expression of a number of
unique genes, including arg1, which are transcriptionally activated
by IL-4 through a STAT6-dependent mechanism [70,71]. STAT6
is considered to be the central regulator of alternative macrophage
activation [36]. While STAT6 may be activated by other stimuli
such as IL-15, platelet-derived growth factor, kit ligand, and leptin,
the canonical pathway for STAT6 activation is through IL-4 or
IL-13 (reviewed in [72]). With this understanding, it is not
surprising that the prevailing paradigm is that alternative
activation of macrophages during murine L. major infection is a
downstream effect of the dominant Th2 polarization and type 2
knockdown on arg1 and STAT6 mRNA expression. BHK cells were transfected with a non-targeting miRNAi vector (control) or a vector specific to
hamster STAT6 and the expression of arg1 and STAT6 mRNA determined by real time RT-PCR in uninfected (open bars) and 24-hr infected cells (filled
bars). The data are presented as the mean and standard deviation (error bars) of the fold-increase of arg1 mRNA relative to BHK cells, determined by
real time RT-PCR from a single experiment, representative of 2 independent experiments. H) miRNAi-mediated STAT-6 knockdown in BHK cells. The
expression of STAT-6 protein in BHK cells stably transfected with a miRNAi vector targeting STAT-6 (STAT-6 KD) or transfected with a miRNAi vector
coding a control sequence (Control) was determined by western blot using an anti-STAT6 antibody. An anti-GAPDH antibody was used to confirm
equivalent protein loading. Data are from a single blot representative of 2 independent experiments. I) Effect of miRNAi-mediated STAT6 knockdown
on parasite burden was determined in BHK cells that were transfected with a non-targeting miRNAi vector (control) or a vector specific to hamster
STAT6. The transfected cells were infected with L. donovani metacyclic promastigotes and the mean and standard deviation (error bars) of the
parasite burden at 4, 24, 48, and 72 hrs post-infection, determined by luminometry, is shown as data pooled from 2 independent experiments. There
was no difference in parasite burden between the two groups at 4 hrs post-infection. The statistical significance of differences between groups in
each of the panels is identified by asterisks (*, p,0.05; **, p,0.01; ***, p,0.001).
doi:10.1371/journal.ppat.1002417.g007
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IL-13/IL-4Ra/STAT6 signaling pathway has a well-established
role in the pathogenesis of cutaneous L. major and L. mexicana
infection in mice [73,74]. However, these studies in the murine
model focused on the effects of STAT6 deficiency in the T cell
compartment without addressing the role of STAT6 in macro-
phages [74,75]. We found that exposure of macrophages or
fibroblasts to L. donovani led to activation of STAT6 (measured
using an in vitro reporter assay, flow cytometry of infected
macrophages and fibroblasts, and western blotting of phospho-
STAT6) even in the absence of T cell signals or exogenous type 2
cytokines. The parasite-induced host arg1 expression was
completely abolished by miRNAi-mediated knockdown of
STAT6, and interruption of this pathway either by STAT6 or
arg1 knockdown enhanced the control of intracellular parasite
replication.
Although it has not been thoroughly studied, fibroblasts can be
polarized by exposure to IL-4, resulting in STAT6 activation [76]
and expression of arginase and other markers that are expressed
by alternatively activated macrophages [77,78]. Leishmania are
known to infect fibroblasts [79,80], and stromal cells are
increasingly being recognized as modulators of host defense
(reviewed in [81]). The finding of arg1 expression in splenic
fibroblasts from hamsters with VL, and in fibroblasts infected in
vitro with L. donovani, suggests that the ‘‘alternatively activated’’
phenotype extends to splenic stromal cells in VL, which are likely
to contribute to the pathogenesis of the disease. The fact that IL-4
alone did not induce arginase activity in BHK fibroblasts supports
the notion that the Leishmania-induced arg1 is driven through an
IL-4-independent pathway in this cell.
Although early de novo synthesis of either an autocrine or
paracrine protein was required for arg1 mRNA expression, this yet
to be identified factor did not appear to be IL-4 or IL-13 since
there was no increase in endogenous expression of these cytokines
in the in vitro infected cell culture where parasite-induced STAT6
activation and arg1 expression were evident. This is not to say that
signaling through IL-4/IL-13/IL-4Ra/STAT6 has no role in the
pathogenesis of VL. The addition of exogenous IL-4 to the in vitro
infection model clearly amplified the parasite-induced arg1
expression, and our in vivo data suggest that the prominent type
2 cytokine expression that is evident late in the course of VL serves
to amplify arg1 expression and the alternative activation
phenotype, and thus contributes to the relentlessly progressive
infection. In human visceral and cutaneous leishmaniasis, there is
increased expression of the type 2 cytokines at the site of chronic
and severe infection [13,14,23,82–84], but the role of these
cytokines in the pathogenesis of human infection has not been fully
defined. Other signaling molecules could also interface with this
pathway to influence arg1 expression. A number of co-activator
proteins, including, p100, CBP/p300, SRC-1, RNA pol II, PU.1,
and C/EBP, are recruited with STAT6 to form a complex
enhancer element in the promoter to initiate in arg1 transcription
[85–87]. Of particular note, C/EBPb may be activated by the IL-
10/STAT3 pathway [88,89]. The potential for synergistic
interaction of the IL-4/IL-13/STAT6 and IL-10/STAT3 path-
ways was not fully appreciated until the recent work of Biswas, et
al, who found that IL-10 expressed in the spleens of mice infected
with L. donovani induced the upregulation of IL-4Ra, which was
required for arg1 expression [68]. Identification of co-activators
and additional pathways that contribute to STAT6-dependent L.
donovani-induced arg1 expression in this model of progressive VL is
currently under investigation.
A number of host factors other than type 2 cytokines can induce
a macrophage activation profile that overlaps the classic IL-4- and
IL-13-induced alternative macrophage activation [36], and could
be contributing as an autocrine or paracrine factor in the L.
donovani-induced arginase activity. These include the STAT3-
activating cytokines IL-10, IL-6, and G-CSF [90,91], TGF-b [46],
cAMP [92], and PGE2 [93]. Of these, IL-10 is particularly
noteworthy for several reasons: (1) IL-10 is increased in patients
[13,14,19,22-25] and hamsters with VL ([60] and current work),
(2) in vitro neutralization of IL-10 in cultures of peripheral blood
mononuclear cells from patients with VL led to recovery of
suppressed Th1 responses [12,26], (3) parasite replication in
human macrophages was enhanced by exposure to recombinant
IL-10 [94], (4) neutralization of IL-10 in serum from patients with
VL cultured with in vitro infected macrophages, or in cultured
splenic aspirates of patients with VL resulted in reduced parasite
burden [19,27], and (5) IL-10 deficient mice show increased
resistance to experimental L. donovani infection [5,6]. As noted
above, the recently described synergy between IL-4/STAT6 and
IL-10/STAT3 in the murine model of L. donovani infection [68]
suggests that IL-10 could augment the STAT6-dependent arg1
expression in the hamster model.
The role of arginase in the pathogenesis of human VL is
uncertain. Polarization of isolated human macrophages by
exposure to IL-4 in vitro does not lead to upregulation of arginase
activity or arg1 expression [95]. However, the presence of
alternatively activated monocytes/macrophages and arginase
expression has been found in some human disease states. Human
filarial infection is associated with enhanced expression of a
number of genes related to alternative activation in peripheral
blood mononuclear cells, including arg1 [96]. Arginase activity
and arg1 expression were also increased in peripheral blood
mononuclear cells from patients following traumatic tissue injury
[97]. The expression of arginase by myeloid cells in the human
tumor microenvironment is well established [98,99]. Studies of the
role of AAMs and arginase in the pathogenesis of human VL are
certainly warranted.
While alternatively activated macrophages have been described
in a number of protozoan and metazoan infections (reviewed in
[100,101]), rarely has a parasite antigen or product been found to
directly induce arginase in isolated macrophages. We found that
STAT6 activation and arg1 transcription could be initiated
through parasite-derived soluble factors and did not require
parasite contact or internalization by the host cell. Stempin et al
[39] found that the cruzipain antigen from Trypanosoma cruzi
directly induced the expression of host arignase. Recently, a
proteophosphoglycan produced by L. mexicana within the sand fly
vector was shown to induce arginase activity in inflammatory
macrophages and enhance intracellular parasite replication [102].
In addition, Toxoplasma gondii was found to activate STAT6 directly
[103], and induce arginase through TLR-dependent, but STAT6-
independent pathway [104]. Lastly, it was demonstrated that the
Ym1, another marker of alternative activation, was induced in
macrophages exposed to a helminth antigen [105]. Work is
underway to identify the soluble L. donovani factor(s) that induce
macrophage arg1.
Collectively, these data lead us to propose a new model in which
ineffective classical macrophage activation in experimental VL,
which is reminiscent of human VL, is associated with, and perhaps
enables, the emergence of a dominant program of STAT6-
dependent alternative macrophage (and fibroblast) activation with
impaired control of parasite replication. The metabolism of
arginine through the arginase-polyamine pathway not only
redirects arginine away from the generation of NO by NOS2,
but also favors the production of polyamines, which promote
parasite replication. That the type 2 cytokines can drive alternative
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greatest significance of our findings is that L. donovani can activate
macrophage and fibroblast STAT6 and induce arg1 expression
without synthesis of endogenous IL-4 or IL-13 or stimulation by
exogenous cytokines. We postulate that in progressive VL these
cytokines serve as an amplification factor for macrophages that
have already started down the alternative activation pathway
through interaction with L. donovani or a soluble parasite factor or
factors. This notion is supported by the dramatic increase in
parasite burden that accompanies the type 2 cytokine response
first evident several weeks into the course of infection. Further
dissection of the pathway by which L. donovani drives host arg1
expression may identify unique pathogenic mechanisms and
targets for therapeutic intervention.
Supporting Information
Figure S1 Polyamine content in spleen and liver tissue
in L. donovani infected mice. The concentration of
polyamines in spleen and liver from groups of 5 uninfected mice
(open bars) and 5 infected mice (filled bars) is expressed as the
mean and standard deviation (error bars) of nmol polyamine per
mg protein. The data shown are from a single experiment that is
representative of 2 independent experiments. There were no
statistically significant differences between the uninfected and
infected tissue samples.
(TIF)
Figure S2 L. donovani infection of BHK cells. BHK cells
were infected at 10:1 ratio with L. donovani promastigotes for 4 hours
and then the extracellular parasites were removed by washing 3
times with PBS and once with 0.1% trypsin/EDTA (Gibco) in
PBS for 3 min at 37uC. After the last wash the BHK monolayer
was detached with 0.25% trypsin and the cells collected by
centrifugation at 400 x g for 5 min. The pelleted cells were
adjusted to 200,000 cells/200 mL of culture medium, transferred
to 4-well chamber slides, and incubated for 24 h at 37uC, 5%
CO2. (A-B) Intracellular amastigotes were imaged at 406
magnification after nuclear labeling with 2 mg/mL Hoechst
33342 (Molecular Probes, Invitrogen) for 5 min. A BHK nucleus
is shown by an arrowhead and amastigotes are identified by
arrows. In some instances the amastigotes are oriented so that the
kinetoplast DNA is clearly visible. (C) L. donovani amastigotes in
BHK cells imaged at 100X magnification after staining with
Hoechst 33342 and (D) 100 nM Lysotracker Red DND-99
(Molecular Probes, Invitrogen) to stain the phagolysosome. (E)
Overlay of the Hoechst and Lysotracker Red stained images using
the NIS-Elements Software (Nikon) to confirm the intraphagoly-
sosmal location of the amastigotes.
(TIF)
Figure S3 Anti-Leishmania activity of the inhibitor nor-
NOHA (Nv-hydroxy-nor-Arginine). (A) Arginase activity was
measured in supernatants of L. donovani-infected hamster perito-
neal macrophages after incubation with or without nor-NOHA for
48 h. The data is shown as the mean and standard deviation (error
bars) of the arginase activity determined by assay of urea
production in 100,000 cells. Statistical differences are shown
between untreated and treated samples. (B) Number of amasti-
gotes in L. donovani-infected hamster peritoneal macrophages after
incubation with or without nor-NOHA for 48 h. The data is
shown as the mean and standard deviation (error bars) of the
number of parasites determined by luminometry. (C) Number of
amastigotes in splenic macrophages isolated from hamsters at 15
days post-infection and untreated or treated ex vivo for 48 h with
nor-NOHA. The data is shown as the mean and standard
deviation (error bars) of the number of parasites determined by
luminometry. (D) Number of amastigotes (purified from infected
hamster spleen) after 24 h of in vitro culture with or without nor-
NOHA (seeded at 100,000 amastigotes/100 mL). The data is
shown as the mean and standard deviation (error bars) of the
number of parasites determined by luminometry. (E) Number of
promastigotes after 24h of in vitro culture with or without
norNOHA (seeded at 100,000 amastigotes/100 mL). The data is
shown as the mean and standard deviation (error bars) of the
number of parasites determined by luminometry. The data shown
for each of the panels is from a single experiment representative of
at least 2 independent experiments. The statistical significance of
differences between groups in each of the panels is identified by
asterisks (*, p,0.05; **, p,0.01; ***, p,0.001).
(TIF)
Figure S4 Effect of opsonization on L. donovani-induced
STAT-6 activation. BHK cells transfected with a STAT6-
luciferase reported vector were exposed or not to unopsonized, or
complement opsonized (fresh hamster serum), or heat killed L.
donovani promastigotes. Data are presented as the mean and
standard deviation (error bars) of the relative light units in
uninfected (Un) cells and cells exposed to 10 parasites per cell over
48 hrs of culture. Shown is data from a single experiment that is
representative of 2 independent experiments. The statistical
significance of differences between uninfected and parasite-
exposed groups is identified by asterisks (*, p,0.05).
(TIF)
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